Abstract
The stimulatory effects of norepinephrine, isoproterenol and selective ß3-adrenoceptor agonists BRL 37344 and CL 316.243 on the adenylyl cyclase signaling system (ACSS) in the brain and myocardium of young and mature rats with experimental obesity and type 2 diabetes mellitus (DM2) (disease induction at 2 and 4 months of age, respectively) and the influence of the long-term intranasal insulin (I-I) administration were studied. It was shown that the AC-stimulatory effects of ß-agonist isoproterenol in animals with obesity and DM2 practically did not change. The respective effects of norepinephrine on the AC activity slackened in the brain of young and mature rats and myocardium of mature rats, while the I-I treatment led to their partial recovery. In the brain and myocardium of mature rats with obesity and DM2 an increase in the AC-stimulatory effects of ß3- AR agonists was observed, while in young rats the similar influence of the same pathologies was mißsing. The I-I treatment resulted in an attenuation of the AC-stimulatory effects of ß3-agonists to their control level. Since the disruption of the adrenergic agonist-sensitive ACSS is one of the causes of metabolic syndrome and DM2, the recovery of ACSS dysfunctions by the long-term I-I administration offers one of the ways of correcting these diseases and their complications in the nervous and cardiovascular systems.
Similar content being viewed by others
References
Dinçer, U.D., Bidasee, K.R., Güner, S., Tay, A., Ozçelikay, A.T., and Altan, V.M., The effect of diabetes on expression of beta1-, beta2-, and be-ta3-adrenoreceptors in rat hearts, Diabetes, 2001, vol. 50, pp. 455–461.
Huisamen, B., Marais, E., Genade, S., and Lochner, A., Serial changes in the myocardial beta-adrenergic signalling system in two models of noninsulin dependent diabetes mellitus, Mol. Cell. Biochem., 2001, vol. 219, pp. 73–82.
Skeberdis, V.A., Structure and function of beta3-adrenergic receptors, Medicina (Kaunas), 2004, vol. 40, pp. 407–413.
Shpakov, A.O., Alterations in hormonal signaling systems in diabetes mellitus: origin, causality and specificity, Endocrinology & Metabolic Syndrome, 2012, vol. 1, pp. 106–108.
Gros, J., Manning, B.S., Pietri-Rouxel, F., Guillaume, J.L., Drumare, M.F., and Strosberg, A.D., Site-directed mutagenesis of the human beta3- adrenoceptor-transmembrane residues involved in ligand binding and signal transduction, Eur. J. Biochem., 1998, vol. 251, pp. 590–596.
Lenard, N.R., Prpic, V., Adamson, A.W., Rogers, R.C., and Gettys, T.W., Differential coupling of ß3A- and ß3B-adrenergic receptors to endogenous and chimeric Gαs and Gαi, Am. J. Physiol. Endocrinol. Metab., 2006, vol. 291, pp. E704–E715.
Seifert, R., Wenzel-Seifert, K., Arthur, J.M., Jose, P.O., and Kobilka, B.K., Efficient adenylyl cyclase activation by a ß2-adrenoreceptor-Giα2 fusion protein, Biochem. Biophys. Res. Commun., 2002, vol. 298, pp. 824–828.
Martin, N.P., Whalen, E.J., Zamah, M.A., Pierce, K.L., and Lefkowitz, R.J., PKA-mediated phosphorylation of the ß1-adrenergic receptor promotes Gs/Gi switching, Cell Signal., 2004, vol. 16, pp. 1397–1403.
Adigun, A.A., Wrench, N., Levin, E.D., Seidler, F.J., and Slotkin, T.A., Neonatal parathion exposure and interactions with a high-fat diet in adulthood: Adenylyl cyclase-mediated cell signaling in heart, liver and cerebellum, Brain Res. Bull., 2010, vol. 81, pp. 605–612.
Matsumoto, T., Wakabayashi, K., Kobayashi, T., and Kamata, K., Functional changes in adenylyl cyclases and associated decreases in relaxation responses in mesenteric arteries from diabetic rats, Am. J. Physiol., 2005, vol. 289, pp. 2234–2243.
Shpakov, A.O. and Derkach, K.V., The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus, J. Signal Transduction, 2013, Article ID 594213, 16 pages.
Gando, S., Hattori, Y., Akaishi, Y., Nishihira, J., and Kanno, M., Impaired contractile response to beta adrenoreceptor stimulation in diabetic rat hearts: alterations in beta adrenoreceptors-G protein-adenylate cyclase system and phospholamban phosphorylation, J. Pharmacol. Exp. Ther., 1997, vol. 282, pp. 475–484.
Woods, S.C., Seeley, R.J., Rushing, P.A., D’Alessio, D.D., and Tso, P., A controlled highfat diet induces an obese syndrome in rats, J. Nutr., 2003, vol. 133, pp. 1081–1087.
Rozec, B. and Gauthier, C., ß3-adrenoceptors in the cardiovascular system: putative roles in human pathologies, Pharmacol. Ther., 2006, vol. 111, pp. 652–673.
Altan, V.M., Arioglu, E., Guner, S., and Ozcelikay, A.T., The influence of diabetes on cardiac beta-adrenoceptor subtypes, Heart Fail. Rev., 2007, vol. 12, pp. 58–65.
Masuo, K., Rakugi, H., Ogihara, T., Esler, M.D., and Lambert, G.W., Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance, Curr. Diabetes Rev., 2010, vol. 6, pp. 58–67.
Boyda, H.N., Procyshyn, R.M., Pang, C.C., and Barr, A.M., Peripheral adrenoceptors: the impetus behind glucose dysregulation and insulin resistance, J. Neuroendocrinol., 2013, vol. 25, pp. 217–228.
Shpakov, A.O., Kuznetsova, L.A., Plesneva, S.A., Guryanov, I.A., and Pertseva, M.N., Molecular causes of alterations in the sensitivity of adenylyl cyclase signaling system in the heart muscle to biogenic amines under experimental streptozotocininduced diabetes mellitus, Tsitol., 2005, vol. 47 pp. 540–548.
Shpakov, A.O., Kuznetsova, L.A., Plesneva, S.A., and Pertseva, M.N., Alterations in the sensitivity of ACSS to biogenic amines and peptide hormones in the tissues of starving rats, Bull. Exper. Biol. Med., 2007, vol. 144, pp. 15–19.
Kuznetsova, L.A., Plesneva, S.A., Sharova, T.S., and Pertseva, M.N., A study of hormone reactivity of adenylyl cyclase signaling system in erythrocytes of patients with type 2 diabetes mellitus, Patol. Fiziol. Eksp. Terap., 2013, vol. 1, pp. 45–49.
Pertseva, M.N. and Shpakov, A.O., A concept of molecular defects in hormonal signaling systems as a cause of endocrine diseases, Sechenov Ross. Fiziol. Zh., 2004, vol. 90, pp. 446–447.
Pertseva, M.N. and Shpakov, A.O., A hypothesis of evolutionary origin of some diseases in humans and animals, Zh. Evol. Biokh. Fiziol., 2010, vol. 46, pp. 261–267.
Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C.L., and Ramarao, P., Combination of high-fat diet-fed and low-dose streptozotocin-induced rat: a model for type 2 diabetes and pharmacological screening, Pharmacol. Res., 2005, vol. 52, pp. 313–320.
Zhang, T., Pan, D.S., Zhao, B., Zhang, L.M., Huang, Y.L., and Sun, F.Y., Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of ß-secretase activation and ß-amiloid generation in rat brains, Neuroscience, 2009, vol. 161, pp. 1045–1056.
Dhuria, S.V., Hanson, L.R., and Frey, W.H., Intranasal delivery to the central nervous system: mechanisms and experimental considerations, J. Pharm. Sci., 2011, vol. 99, pp. 1654–1673.
Benedict, C., Brede, S., Schiöth, H.B., Lehnert, H., Schultes, B., Born, J., and Hallschmid, M., Intranasal insulin enhances postprandial thermogenesis and lowers postprandial serum insulin levels in healthy men, Diabetes, 2011, vol. 60, pp. 114–118.
Ott, V., Benedict, C., Schultes, B., Born, J., and Hallschmid, M., Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism, Diabetes Obes. Metab., 2012, vol. 14, pp. 214–221.
Heni, M., Kullmann, S., Ketterer, C., Guthoff, M., Linder, K., Wagner, R., Stingl, K.T., Veit, R., Staiger, H., Hring, H.U., Preissl, H., and Fritsche, A., Nasal insulin changes peripheral insulin sensitivity simultaneously with altered activity in homeostatic and reward-related human brain regions, Diabetologia, 2012, vol. 55, pp. 1773–1782.
Gasparetti, A.L., Alvarez-Rojas, F., de Araujo, E.P., Hirata, A.E., Saad, M.J., and Velloso, L.A., ß3-adrenergic-dependent and independent mechanisms participate in cold-induced modulation of insulin signal transduction in brown adipose tissue of rats, Pflügers Arch., 2005, vol. 449, pp. 537–546.
Jost, P., Fasshauer, M., Kahn, C.R., Benito, M., Meyer, M., Ott, V., Lowell, B.B., Klein, H.H., and Klein, J., Atypical ß-adrenergic effects on insulin signaling and action in ß3-adrenoceptordeficit brown adipocytes, Am. J. Physiol., 2002, vol. 283, pp. 146–153.
Tully, K. and Bolshakov, V.Y., Emotional enhancement of memory: how norepinefrine enables synaptic plasticity, Molecular Brain, 2010, vol. 3, pp. 15–25.
Scheen, A.J., Central nervous system: a conductor orchestrating metabolic regulations harmed by both hyperglycaemia and hypoglycaemia, Diabetes Metabolism, 2010, vol. 36, pp. S31–S38.
Chavali, V., Tyagi, S.C., and Mishra, P.K., Predictors and prevention of diabetic cardiomyopathy, Diabetes, Metabolic Syndrome, Obesity, 2013, vol. 6, pp. 151–160.
Picchi, A., Capobianco, S., Qju, T., Focardi, M., Zou, X., Cao, J.M., and Zhang, C., Coronary microvascular disfunction in diabetes mellitus: a review, World J. Cardiology, 2010, vol. 2, pp. 377–390.
Vicario, P.P., Candelore, M.R., Schaeffer, M.T., Kelly, L., Thompson, G.M., Brady, E.J., Saperstein, R., Mac Intyre, D.E., Tota, L.M., and Cascieri, M.A., Desensitization of beta3-adrenergic receptor-stimulated adenylyl cyclase activity and lipolysis in rats, Life Sci., 1998, vol. 162, pp. 627–638.
Ren, C.J., Zhang, Y., Cui, W.Z., and Mu, Z.M., Progress in the role of oxidative stress in the pathogenesis of type 2 diabetes, Sheng Li Xue Bao., 2013, vol. 65, pp. 664–673.
Soumaya, K., Molecular mechanisms of insulin resistance in diabetes, Adv. Exp. Med. Biol., 2012, vol. 771, pp. 240–251.
Shpakov, A.O., Derkach, K.V., Moyseyuk, I.V., Chistyakova, O.V., and Bondareva, V.M., Hormonal sensitivity of adenylyl cyclase system in the myocardium, brain and testes of 18-month-old nondiabetic and diabetic rats, Int. J. Biochem. Res., 2013, vol. 3, pp. 1–20.
Banyasz, T., Kalapos, I., Kelemen, S.Z., and Kovacs, T., Changes in cardiac contractility in IDDM and NIDDM diabetic rats, Gen. Physiol. Biophysics, 1996, vol. 15, pp. 357–369.
Mishra, P.K., Awe, O., Metreveli, N., Oipshidze, N., Joshua, I.G., and Tyagi, S.C., Exercise mitigates homocysteine-ß2-adrenergic receptor interactions to ameliorate contractile dysfunction in diabetes, Int. J. Physiol. Pathophysiol. Pharmacol., 2011, vol. 3, pp. 97–106.
Magnoni, M.S., Kobayashi, H., and Trezzi, E., ß-adrenergic receptors in brain microvessels of diabetic rats, Life Sciences, 1984, vol. 34, pp. 1095–1100.
Shpakov, A.O., Derkach, K.V., Chistyakova, O.V., Sukhov, I. B., Shipilov, V.N., and Bondareva, V.M., The brain adenylyl cyclase signaling system and cognitive functions in rat with neonatal diabetes under the influence of intranasal serotonin, J. Metabolic Sindrome, 2012, vol. 1, http://dx.doi.org/10.4172/jms.1000104.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L. A. Kuznetsova, T.S. Sharova, M.N. Pertseva, A.O. Shpakov, 2015, published in Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, 2015, Vol. 51, No. 3, pp. 170—180.
Deceased.
Rights and permissions
About this article
Cite this article
Kuznetsova, L.A., Sharova, T.S., Pertseva, M.N. et al. Beta-adrenergic regulation of adenylyl cyclase signaling system in the myocardium and brain of rats with obesity and type 2 diabetes mellitus as affected by long-term intranasal insulin administration. J Evol Biochem Phys 51, 198–209 (2015). https://doi.org/10.1134/S0022093015030040
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0022093015030040